Send Inquiry

Request To Call Back

100mg Palbociclib Capsules

Get a Price/Quote

MOQ : 100 Boxes

100mg Palbociclib Capsules Specification

Origin of Medicine
India

Life Span
24 months from date of manufacture

Salt Composition
Palbociclib 100mg

Pacakaging (Quantity Per Box)
21 capsules

Dosage Form
Capsule

Brand Name
Palbace

Indication
Treatment of HR+/HER2- advanced or metastatic breast cancer

Packaging Type
Blister pack

Drug Type
Allopathic

Ingredients
Palbociclib 100mg

Physical Form
Capsule

Function
Anti-cancer, CDK4/6 inhibitor

Recommended For
Adults with HR-positive, HER2-negative advanced or metastatic breast cancer

Dosage
As prescribed by physician, commonly 125 mg once daily for 21 consecutive days followed by 7 days off, dosage adjusted to 100mg if needed

Dosage Guidelines
Oral, to be taken with food

Suitable For
Women, Adults

Quantity
21 Capsules per box

Storage Instructions
Store below 30C, protect from moisture and light

Container Type
Aluminium blister strip

Patient Information Leaflet
Included in package

Marketed By
Pfizer Ltd. (Brand Name: Palbace)

Therapeutic Class
Oncology

Administration Route
Oral

Regulatory Approval
US FDA, EMA, DCGI (India) approved

Prescription/Non Prescription
Prescription only

Side Effects
Neutropenia, leukopenia, fatigue, nausea

Warning & Precaution
Use with caution in patients with liver impairment, avoid during pregnancy and lactation

Color
Opaque Pink

Shelf Life After Opening
Keep capsules tightly closed; use within expiry date

100mg Palbociclib Capsules Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 100mg Palbociclib Capsules

Unlock a pivotal advancement in the fight against advanced breast cancer with Palbace (Palbociclib 100mg) Capsules from Pfizer Ltd. Tailored for women and adults, this first-string oncology solution stands as a paragon of targeted therapy, inhibiting CDK4/6 to treat HR+/HER2- advanced or metastatic breast cancer. Available by prescription only, Palbace features an opaque pink, oral capsule form packaged in secure aluminium blister strips. With approvals from the US FDA, EMA, and DCGI (India), and built-in patient information, its safety and effectiveness are trusted worldwide. Special sale-stock ready for immediate dispatch!

Application, Usage, and User Groups

Palbace 100mg Capsules are designed for oral administration and are best taken with food as instructed by a healthcare provider. Primarily used by adult women diagnosed with HR-positive, HER2-negative advanced or metastatic breast cancer, these capsules function as a targeted CDK4/6 inhibitor. Palbociclib is used strictly as an anti-cancer pharmaceutical under medical supervision, ensuring optimal results when integrated into a prescribed oncology treatment regimen.

Certifications, Samples, and Payment Options

Benefit from premium, US FDA, EMA, and DCGI certified Palbociclib stock-ready for express shipping directly from India. Each box contains 21 accurately dosed capsules, secured in aluminium blister packaging. Samples can be arranged for eligible programs or medical assessment. Flexible payment terms are available to ensure seamless procurement for healthcare institutions and authorized traders. Act now to take advantage of our special sale-supply is limited!

FAQ's of 100mg Palbociclib Capsules:

Q: How should Palbociclib 100mg Capsules be administered?

A: Palbociclib 100mg Capsules should be taken orally, ideally with food, according to the dosage regimen prescribed by your physician. Swallow the capsule whole without crushing or chewing.

Q: What are the main benefits of Palbace (Palbociclib) for patients?

A: Palbace targets CDK4/6, helping to slow down cancer cell progression in patients with HR-positive, HER2-negative advanced or metastatic breast cancer, enhancing treatment outcomes when used as part of a comprehensive therapy plan.

Q: When should I avoid using Palbociclib Capsules?

A: Palbociclib Capsules should be avoided during pregnancy and lactation, and patients with liver impairment should use them with extra caution as advised by their healthcare provider.

Q: What side effects might occur with Palbociclib Therapy?

A: Some commonly reported side effects include neutropenia, leukopenia, fatigue, and nausea. Always consult your physician if you experience unusual symptoms.

Q: Where is Palbociclib (Palbace) manufactured and marketed?

A: Palbace is manufactured and marketed by Pfizer Ltd. in India, with regulatory approval from international authorities including the US FDA, EMA, and DCGI (India).

Q: What are the packaging and storage instructions for Palbociclib 100mg Capsules?

A: Palbace capsules come in aluminium blister strips of 21, should be stored below 30C, protected from moisture and light, and kept tightly closed until expiry.

Q: How can authorized buyers procure Palbace for clinical use?

A: Stock is ready and available for express shipping. Authorized buyers can request samples and benefit from flexible payment terms by contacting the supplier/trader in India.

Tell us about your requirement